Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03138889
Title Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Nektar Therapeutics
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

NKTR-214 + Pembrolizumab

Carboplatin + Nab-paclitaxel + NKTR-214 + Pembrolizumab

Carboplatin + NKTR-214 + Paclitaxel + Pembrolizumab

Cisplatin + NKTR-214 + Pembrolizumab

Carboplatin + NKTR-214 + Pembrolizumab + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU

Additional content available in CKB BOOST